FKBP5 (6G6) Monoclonal Antibody

$Lane 1: Rat Kidney; Lane 2: Daudi Cells; Probed with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:500 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Rat Kidney; Lane 2: Daudi Cells; Probed with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:500 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

$Paraformaldehyde-fixed and paraffin-embedded Human Tonsil tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human Tonsil tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Rat Lung tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Rat Lung tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

Flow cytometric analysis of Daudi cells with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at a 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).

Applications

WB
FCM
IHC-P

Reactivity

Human
Rat

Overview
Catalog #	bsm-54309R
Product Name	FKBP5 (6G6) Monoclonal Antibody
Applications	WB, FCM, IHC-P
Reactivity	Human, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Synthetic peptide corresponding to the C-terminus of human FKBP51
Clonality	Monoclonal
Clone #	6G6
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	2289
Swiss Prot	Q13451
Subcellular location	Cytoplasm, Nucleus
Synonyms	Peptidyl-prolyl cis-trans isomerase FKBP5; 51 kDa FK506-binding protein; 54 kDa progesterone receptor-associated immunophilin; Androgen-regulated protein 6; FF1 antigen; FK506-binding protein 5; FKBP54; HSP90-binding immunophilin; Rotamase; PPIase FKBP5; 51 kDa FKBP; FKBP-51; FKBP-5; p54; FKBP5; AIG6; FKBP51
Background	Immunophilin protein with PPIase and co-chaperone activities. Component of unligated steroid receptors heterocomplexes through interaction with heat-shock protein 90 (HSP90). Plays a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors maintaining the complex into the cytoplasm when unliganded.
Application Dilution
WB	1:300-5000
FCM	1:20-100
IHC-P	1:200-400

Applications

Reactivity

Search our catalog of hundreds of thousands of products